L’Occitane Group agreed to sell British skincare brand Elemis to French private equity firm PAI Partners after net sales at the label topped USD 300 million. The companies announced the agreement on November 4 without disclosing financial terms.

Regulatory approvals will determine the closing timeline, scheduled for the first quarter of 2027. The divestment unwinds the largest acquisition in L’Occitane’s history, completed in 2019 under billionaire owner Reinold Geiger for USD 900 million.

Elemis almost doubled its net sales during its seven years inside the French personal care group. Online platforms generate nearly half of its sales, while the United States accounts for roughly half of its total business.

Geiger bought out minority shareholders and delisted L’Occitane from the Hong Kong Stock Exchange in 2024, ending a 14-year run on the Asian bourse that began in 2010. The group generated EUR 2.8 billion in global net sales for the fiscal year ended March 31, 2025, up 12 per cent year-on-year at constant exchange rates.

“This transaction reflects a disciplined portfolio decision, focused on creating long-term value for the Group,” he said.

L’Occitane spent years pitching its dual French heritage and Asian retail footprint to investors in Hong Kong. Offloading Elemis frees up balance sheet capacity for the group’s faster-growing fragrance and body care divisions, led by Sol de Janeiro alongside Erborian, Melvita and flagship L’Occitane en Provence.

Rival multi-brand conglomerates across Asia have similarly pulled back from bloated brand rosters. Operators in department stores and travel retail hubs must now prepare for PAI to pivot Elemis distribution toward standalone retail and digital channels in Western markets, reallocating counter space that previously leaned on L’Occitane’s corporate muscle.

Source link